参考文献/References:
[1]Kirstein MM, Vogel A. Epidemiology and risk factors of cholangiocarcinoma. Visc Med,2016,32(6):395-400.
[2]Kim HJ, Kim JS, Joo MK, et al. Hepatolithiasis and intrahepatic cholangiocarcinoma: A review. World J Gastroenterol,2015,21(48):13418-13431.
3殷晓煜.胆道外科手术中Oddi括约肌保护的共识与争议.中国实用外科杂志,2015,35(1):46-48.
[4]Doi S, Yasuda I, Mukai T, et al. Comparison of longterm outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation: a propensity scorebased cohort analysis. J Gastroenterol,2013,48(9):1090-1096.
[5]Suzuki Y, Mori T, Yokoyama M, et al. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years. J Hepatobiliary Pancreat Sci,2014,21(9):617-622.
[6]林宇凤,凌晓锋.肝内胆管结石病治疗中Oddi括约肌功能的存废争议.中国微创外科杂志,2016,16(10):931-935.
[7]Kawai K,Nakajima M,Kimoto K,et al.Endoscopic sphincterotomy of the ampulla of Vater and removal of common duct stones.Am J Gastroenterol,1975,64(1):34-43.
[8]Barreda CL, Targarona MJ, Marcos EJ, et al. Knowing an infrequent complication of endoscopic retrograde cholangiopancreatography . Rev Gastroenterol Peru,2017,37(1):39-46.
[9]Lin WC, Lin HH, Hung CY, et al. Clinical endoscopic management and outcome of postendoscopic sphincterotomy bleeding. PloS One,2017,12(5):e177449.
[10]Minami A, Nakatsu T, Uchida N, et al. Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function. Dig Dis Sci,1995,40(12):2550-2554.
[11]Bergman JJ, van Berkel AM, Groen AK, et al. Biliary manometry, bacterial characteristics, bile composition, and histologic changes fifteen to seventeen years after endoscopic sphincterotomy. Gastrointest Endosc,1997,45(5):400-405.
[12]Staritz M, Ewe K, Meyer ZBK. Investigation of the sphincter of Oddi before, immediately after and six weeks after endoscopic papillotomy. Endoscopy,1986,18(1):14-16.
[13]Sugiyama M, Atomi Y. Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: longterm (more than 10 years) followup study . Am J Gastroenterol,2002,97(11):2763-2767.
[14]Fujimoto T, Tsuyuguchi T, Sakai Y, et al. Longterm outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Dig Endosc,2010,22(2):95-100.
[15]Sand J, Airo I, Hiltunen KM, et al. Changes in biliary bacteria after endoscopic cholangiography and sphincterotomy. Am Surg,1992,58(5):324-328.
[16]Kim HJ, Kim JS, Joo MK, et al. Hepatolithiasis and intrahepatic cholangiocarcinoma: A review. World J Gastroenterol,2015,21(48):13418-13431.
[17]Langerth A, Brandt L, Ekbom A, et al. Late Complications following endoscopic sphincterotomy for choledocholithiasis: a Swedish populationbased study. Diagn Ther Endosc,2014,2014:745790.
[18]曾建平,董家鸿. Oddi括约肌:从切开到修复.临床肝胆病杂志,2017,33(2):209-212.
[19]吴硕东,范莹.Oddi括约肌功能研究的现状与临床意义.外科理论与实践,2011,16(4):344-347.
[20]Tazuma S, Nakanuma Y. Clinical features of hepatolithiasis: analyses of multicenterbased surveys in Japan. Lipids Health Dis,2015,14:129.
[21]Kayhan B, Akdogan M, Parlak E, et al. Hepatolithiasis: a Turkey experience. Turk J Gastroenterol,2007,18(1):28-32.
[22]Takezawa M, Kida Y, Kida M, et al. Influence of endoscopic papillary balloon dilation and endoscopic sphincterotomy on sphincter of oddi function: a randomized controlled trial. Endoscopy,2004,36(7):631-637.
[23]Cheon YK, Cho YD, Moon JH, et al. Evaluation of longterm results and recurrent factors after operative and nonoperative treatment for hepatolithiasis. Surgery,2009,146(5):843-853.
[24]Hwang JH, Yoon YB, Kim YT, et al. Risk factors for recurrent cholangitis after initial hepatolithiasis treatment. J Clin Gastroenterol,2004,38(4):364-367.
[25]Tan J, Tan Y, Chen F, et al. Endoscopic or laparoscopic approach for hepatolithiasis in the era of endoscopy in China. Surg Endosc,2015,29(1):154-162.
[26]Ling X, Xu Z, Wang L, et al. Is Oddi sphincterotomy an indication for hepatolithiasis? Surg Endosc,2009,23(10):2268-2272.
[27]Davids PH, Tanka AK, Rauws EA, et al. Benign biliary strictures. Surgery or endoscopy? Ann Surg,1993,217(3):237-243.
[28]Vergaras SF, Lopez AR, Montalva OE, et al. Hepatolithiasis simulating a cholangiocarcinoma. Cir Esp,2013,91(8):535-537.
[29]Joo I, Lee JM. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection . Abdom Imaging, 2013,38(6):1334-1350.
[30]Zhu QD, Zhou MT, Zhou QQ, et al. Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma. World J Surg,2014,38(8):2097-2104.
[31]Suzuki Y, Mori T, Abe N, et al. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese multicenter study.Hepatol Res,2012,42(2):166-170.
[32]Tian J, Li JW, Chen J, et al. Laparoscopic hepatectomy with bile duct exploration for the treatment of hepatolithiasis: an experience of 116 cases.Dig Liver Dis,2013,45(6):493-498.
[33]杨玉龙,冯秋实,张宝善.胆道内镜微创治疗肝内外胆管结石的几点思考.肝胆胰外科杂志, 2011,23(1):80-83.
[34]张宗明,田祖豪,苑海明,等.肝内外胆管结石的微创治疗策略.世界华人消化杂志,2016,24(26):3757-3763.
[35]Huang MH, Chen CH, Yang JC, et al. Longterm outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis. Am J Gastroenterol,2003,98(12):2655-2662.
[36]杨晶,张筱凤.体外冲击波碎石联合ERCP治疗肝内胆管结石.中华消化内镜杂志, 2014,31(5):278-280.